Smoking Status and HbA1c in U.S. Adults Without Diabetes: A Cross-Sectional National Health and Nutrition Examination Survey (NHANES) Analysis

Background: Cigarette smoking is a recognized risk factor for type 2 diabetes, and prior work has reported higher glycated hemoglobin (HbA1c) levels among smokers. Whether this reflects a direct metabolic effect of smoking or residual confounding by central adiposity, systemic inflammation, and lipid dysregulation remains unclear, and whether the association persists after cessation in adults without diabetes has not been fully characterized. Aim: We examined associations between smoking and HbA1c among United States (U.S.) adults, and whether these associations vary by diabetes status. Methods: We analyzed National Health and Nutrition Examination Survey (NHANES) data from 2015-2018 for adults aged ≥20 years. Smoking was assessed by self-report and serum cotinine. Survey-weighted multivariable linear regression was used to evaluate the association between smoking and HbA1c in the full population (N=9,214) and in adults without diabetes (N=7,328), adjusting for demographics, blood pressure, waist circumference, lipids, and high-sensitivity C-reactive protein (hsCRP). Results: After adjustment for cardiometabolic covariates, there was no statistically significant association between smoking and HbA1c in the full population (former: β=0.029%, p=0.30; current: β=0.053%, p=0.13). Among adults without diabetes, former smoking was not associated with HbA1c, whereas current smoking remained significantly associated (former: β=−0.001%, p=0.923; current: β=0.067%, p<0.001). These findings were similar when cotinine was used as the exposure measure, with active smoking (≥3.0 ng/mL) associated with higher HbA1c among non-diabetic adults (p<0.001), but not in the full population. Conclusions: Among adults without diabetes, current smoking was statistically significantly associated with higher HbA1c, whereas former smoking was not. The formal smoking × diabetes interaction test did not reach statistical significance, so the subgroup pattern should be interpreted as hypothesis-generating. The absence of a significant association in former smokers is compatible with attenuation following cessation. These findings may inform cessation counseling and diabetes screening and warrant replication in larger, adequately powered studies.

Authors

Publication Details

Journal
Cureus
Published
2026-05-11
DOI
https://doi.org/10.7759/cureus.108658
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Smoking Status and HbA1c in U.S. Adults Without Diabetes: A Cross-Sectional National Health and Nutrition Examination Survey (NHANES) Analysis

Nnamdi Okoli, Ngozi Ogo, Stephen Adilih, Chibuzo C Manafa et al.
Cureus
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Smoking Status and HbA1c in U.S. Adults Without Diabetes: A Cross-Sectional National Health and Nutrition Examination Survey (NHANES) Analysis

Nnamdi Okoli, Ngozi Ogo, Stephen Adilih, Chibuzo C Manafa, Chukwuzitelu Okafor-Udah, Ndidi-amaka Adilih, Patrick O Manafa
article en

Abstract

Background: Cigarette smoking is a recognized risk factor for type 2 diabetes, and prior work has reported higher glycated hemoglobin (HbA1c) levels among smokers. Whether this reflects a direct metabolic effect of smoking or residual confounding by central adiposity, systemic inflammation, and lipid dysregulation remains unclear, and whether the association persists after cessation in adults without diabetes has not been fully characterized. Aim: We examined associations between smoking and HbA1c among United States (U.S.) adults, and whether these associations vary by diabetes status. Methods: We analyzed National Health and Nutrition Examination Survey (NHANES) data from 2015-2018 for adults aged ≥20 years. Smoking was assessed by self-report and serum cotinine. Survey-weighted multivariable linear regression was used to evaluate the association between smoking and HbA1c in the full population (N=9,214) and in adults without diabetes (N=7,328), adjusting for demographics, blood pressure, waist circumference, lipids, and high-sensitivity C-reactive protein (hsCRP). Results: After adjustment for cardiometabolic covariates, there was no statistically significant association between smoking and HbA1c in the full population (former: β=0.029%, p=0.30; current: β=0.053%, p=0.13). Among adults without diabetes, former smoking was not associated with HbA1c, whereas current smoking remained significantly associated (former: β=−0.001%, p=0.923; current: β=0.067%, p<0.001). These findings were similar when cotinine was used as the exposure measure, with active smoking (≥3.0 ng/mL) associated with higher HbA1c among non-diabetic adults (p<0.001), but not in the full population. Conclusions: Among adults without diabetes, current smoking was statistically significantly associated with higher HbA1c, whereas former smoking was not. The formal smoking × diabetes interaction test did not reach statistical significance, so the subgroup pattern should be interpreted as hypothesis-generating. The absence of a significant association in former smokers is compatible with attenuation following cessation. These findings may inform cessation counseling and diabetes screening and warrant replication in larger, adequately powered studies.

Cureus
Good health and well-being
Openalex Percentile: Top 7%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.